Announcement No.: 2015-002 Stock Code: 833819 Stock Abbreviation: Nutrichem Biological Sponsoring Broker: Southwest Securities

The company and all members of the board of directors guarantee that the content of the announcement is true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal responsibility for the authenticity, accuracy and completeness of its content.

1. Convening of the meeting

The fourth meeting of the first board of directors of Beijing Nutrichem Jiahe Biotechnology Co., Ltd. (hereinafter referred to as the "Company") was held in the company's conference room on November 12, 2015. The meeting was notified in writing on November 2, 2015. Directors. The meeting was presided over by Chairman Jiang Kangwei. There were 5 directors who were supposed to attend and 5 directors actually attended, which complied with the relevant provisions of the Company Law of the People's Republic of China, the Articles of Association and the Rules of Procedure for the Board of Directors.　　

2. Deliberation of the proposal
　　

The Board of Directors reviewed and approved the following matters by way of on-site voting:

1. "Proposal on the Company's Share Issuance Plan";

As the number of unrelated directors present at the board of directors was less than 3, the proposal was submitted to the general meeting of shareholders for deliberation in accordance with the Articles of Association;

2. "Proposal on the Share Subscription Agreement for this Share Issuance";

As the number of unrelated directors present at the board of directors was less than 3, the proposal was submitted to the general meeting of shareholders for deliberation in accordance with the Articles of Association;

3. To consider and approve the "Proposal on Amending the Articles of Association" and submit it to the 2nd Extraordinary General Meeting of Shareholders in 2015 for deliberation;

Voting situation: 5 votes in favor, 0 votes against, and 0 abstentions.

4. Reviewed and approved the "Proposal on Requesting the Company's General Meeting of Shareholders to Authorize the Board of Directors to Fully Handle Specific Matters Related to Stock Issuance and Listing and Market Making", and submitted it to the 2nd Extraordinary General Meeting of Shareholders in 2015 for deliberation;

Voting situation: 5 votes in favor, 0 votes against, and 0 abstentions.

5. Reviewed and approved the "Proposal on Approving the Company's Shares by Market Making and Transfer", and submitted it to the 2nd Extraordinary General Meeting of Shareholders in 2015 for deliberation;

Voting situation: 5 votes in favor, 0 votes against, and 0 abstentions.

6. Reviewed and approved the Proposal on Purchasing Intangible Assets such as Product Registration Certificates and Product Trademarks;

Voting situation: 5 votes in favor, 0 votes against, and 0 abstentions.

7. The Proposal on Holding the 2nd Extraordinary General Meeting of Shareholders in 2015 was reviewed and approved.

Because this stock issuance plan involves the directors, supervisors and wholly-owned subsidiaries of the company's controlling shareholder, Winbond Life & Health Co., Ltd. Regulations and other regulations to perform the corresponding approval procedures for related party transactions, so the company's second extraordinary general meeting in 2015 will be notified separately.

Voting situation: 5 votes in favor, 0 votes against, and 0 abstentions.

3. Documents for reference

"Resolution of the Fourth Meeting of the First Board of Directors of Beijing Nutrichem Jiahe Biotechnology Co., Ltd." signed and confirmed by the participating directors;

  Special announcement!
　　    

Beijing Nutrichem Jiahe Biotechnology Co., Ltd.

      Board of Directors

November 16, 2015